SARS-CoV2 infection was reported to lead to elevated plasma levels of neurofilament light chain protein (NfL) and glial fibrillary acidic protein (GFAP) two markers usually indicative of CNS injury in patients with COVID-19 [83]. Here, NEFL is linked to COVID-19.